Q1 Sales revenue represents a ~$17m annualised run rate (ARR) 

Get Share price going - Activated Probiotics, Activated Nutrients, and AXP. 

BIOME AUSTRALIA LIMITED (ASX:BIO) - Ann: Record quarterly sales revenue for Q1, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum

ASX ANNOUNCEMENT 1 October 2024 Biome reports record quarterly sales revenue for Q1 FY25

● Biome achieves record quarterly sales revenue of ~$4.25m (unaudited)

● Sales revenue increased ~$1.51m or 55% vs PCP Q1 FY24

● Sales revenue increased ~$450k or 12% vs Q4 FY24

● Q1 Sales revenue represents a ~$17m annualised run rate (ARR) Microbiome health company Biome Australia Limited (ASX: BIO) (‘Biome’ or ‘the company’) is pleased to provide a trading update for Q1 FY25. Biome’s quarterly sales revenue totalled ~$4.25m (unaudited), representing a 55% increase vs the previous corresponding period (Q1 FY24, $2.74m) and 12% above the previous record quarter (Q4 FY24, $3.8m).

This result exceeded the $4m target for the quarter (Ref: ASX announcement dated 3 September 2024) by $250k or 6.3%. Biome’s Q1 sales revenue represents an annualised run rate of $17m, with growth expected to continue through the remainder of FY25.

Biome Australia’s Managing Director and Founder, Blair Vega Norfolk, commented: “I am excited to share this result for Q1 FY25, another record quarter in sales revenue following our recent release of Biome’s Vision 27, which outlined our growth plan and prospects over the next three years.

I look forward to sharing further updates on our growth and performance in the coming periods.” -ENDS